Clobetasol Propionate 0.05% Taiyo Uses, Dosage, Side Effects and more
Clobetasol Propionate 0.05% Taiyo is under investigation for the treatment of Scleroderma. Clobetasol Propionate 0.05% Taiyo has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
| Trade Name | Clobetasol Propionate 0.05% Taiyo |
| Availability | Prescription only |
| Generic | Clobetasol |
| Clobetasol Other Names | Clobetasol |
| Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
| Type | |
| Formula | C22H28ClFO4 |
| Weight | Average: 410.907 Monoisotopic: 410.166015296 |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Japan |
| Last Updated: | January 7, 2025 at 1:49 am |
Clobetasol Propionate 0.05% Taiyo Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
